Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome

Cytokine

Volumn 64, Issue 1, 2013, Pages 22-24

  Zhao, Lin ^a,b   Yao, Lutian ^a   Yuan, Lin ^a   Xia, Liping ^a   Shen, Hui ^a   Lu, Jing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 33; Interstitial lung disease; Primary Sjogren's Syndrome; SST2

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 33; LA ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY; SOLUBLE ST2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; EUROPEAN LEAGUE AGAINST RHEUMATISM SJOGREN SYNDROME DISEASE ACTIVITY INDEX; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SJOEGREN SYNDROME;

INTERLEUKIN-33; INTERSTITIAL LUNG DISEASE; PRIMARY SJOGREN'S SYNDROME; SST2;

ANTIBODIES, ANTINUCLEAR; BLOOD SEDIMENTATION; FEMALE; HUMANS; INTERLEUKINS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; RHEUMATOID FACTOR; RIBONUCLEOPROTEINS; SJOGREN'S SYNDROME;

EID: 84883553143     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.07.006     Document Type: Article

References (14)

1. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23(5):479-490.
2. Chackerian A.A., Oldham E.R., Murphy E.E., Schmitz J., Pflanz S., Kastelein R.A. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007, 179(4):2551-2555.
3. Hayakawa H., Hayakawa M., Kume A., Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007, 282(36):26369-26380.
4. Ho L.H., Ohno T., Oboki K., Kajiwara N., Suto H., Iikura M., et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukocyte Biol 2007, 82(6):1481-1490.
5. Hong Y.S., Moon S.J., Joo Y.B., Jeon C.H., Cho M.L. Measurement of interleukin-33(IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci 2011, 26(9):1132-1139.
6. Kamekura R., Kojima T., Takano K., Go M., Sawada N., Himi T. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy 2012, 42(2):218-228.
7. Mok M.Y., Huang F.P., Ip W.K., Lo Y., Wong F.Y., Chan E.Y., et al. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology 2010, 49(3):520-527.
8. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's Syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61(6):554-558.
9. Xiangyang Z., Lutian Y., Lin Z., Liping X., Hui S., Jing L. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine 2012, 58:6-9.
10. Matsuyama Y., Okazaki H., Tamemoto H., Kimura H., Kamata Y., Nagatani K., et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheumatol 2010, 37(1):18-25.
11. Mu R., Huang H.Q., Li Y.H., Li C., Ye H., Li Z.G. Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis. J Rheumatol 2010, 37(10):2006-2013.
12. Yang Z., Liang Y., Xi W., Li C., Zhong R. Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin Exp Med 2011, 11(2):75-80.
13. Yasuda K., Muto T., Kawagoe T., Matsumoto M., Sasaki Y., Matsushita K., et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci USA 2012, 109(9):3451-3456.
14. Aoki S., Hayakawa M., Ozaki H., Takezako N., Obata H., Ibaraki N., et al. ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells. Mol Cell Biochem 2010, 335(1-2):75-81.